HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activating Transcription Factors

Activating transcription factors were originally identified as DNA-BINDING PROTEINS that interact with early promoters from ADENOVIRUSES. They are a family of basic leucine zipper transcription factors that bind to the consensus site TGACGTCA of the cyclic AMP response element, and are closely related to CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN.
Also Known As:
ATF Transcription Factors; Factors, ATF Transcription; Transcription Factors, ATF
Networked: 32 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Malik, Amal Idris: 1 article (04/2022)
2. Storey, Janet M: 1 article (04/2022)
3. Storey, Kenneth B: 1 article (04/2022)
4. Aydemir, Esra: 1 article (01/2020)
5. Bayrak, Ömer Faruk: 1 article (01/2020)
6. Kaşıkcı, Ezgi: 1 article (01/2020)
7. Şahin, Fikrettin: 1 article (01/2020)
8. Ma, Shuangyu: 1 article (10/2019)
9. Sun, Xiaoli: 1 article (10/2019)
10. Zhai, Hongjun: 1 article (10/2019)

Related Diseases

1. Neoplasms (Cancer)
2. Insulin Resistance
3. Inflammation (Inflammations)
4. Hypoxia (Hypoxemia)
5. Colonic Neoplasms (Colon Cancer)
03/01/2014 - "Treatment of colon cancer cells with 3-AP or 3-AP-Me activated all three ER stress pathways (PERK, IRE1a, ATF6) by phosphorylation of eIF2α and upregulation of gene expression of activating transcription factors ATF4 and ATF6. "
11/01/2022 - ": LPS, lipopolysaccharide; TLR, Toll-like receptor; MD-2, myeloid differentiation factor 2; CD14, cluster of differentiation 14; LBP, lipopolysaccharide-binding protein; MYD88, myeloid differentiation primary response 88; NF-κB, nuclear factor kappa light-chain enhancer of activated B cells; MAPK, mitogen-activated protein kinase; IL, interleukin; TNFα, tumor necrosis factor-alpha; Caco-2, cyanocobalamin uptake by human colon adenocarcinoma cell line; MLCK, myosin light-chain kinase; TJ, tight junction; IκBα, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; IBS, irritable bowel syndrome; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase (JNK; GVB, gut-vascular barrier; ApoM, apolipoprotein M; S1P, sphingosine-1-phosphate; VE-cadherin, vascular endothelial cadherin; AJ, adherens junction; PV1, plasmalemma vesicle-associated protein-1; HDL, high-density lipoprotein; Wnt, wingless-related integration site; Fzd, 7-span transmembrane protein Frizzled; LRP, low-density lipoprotein receptor-related protein; TEER, transendothelial/transepithelial electrical resistance; COX-2, cyclooxygenase-2; iNOS, inducible nitric oxide synthase; IGF, insulin-like growth factor; IGFBP, insulin-like growth factor-binding protein; ZIP, Zrt-Irt-like protein; PPAR, peroxisome proliferator-activated receptors; p-PPAR, phosphorylated-peroxisome proliferator-activated receptors; ATF, activating transcription factors; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; SARA, subacute ruminal acidosis; IPEC-J2, porcine intestinal epithelial cells; ALI, acute lung injury; ARDS, acute respiratory distress syndrome."

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Triglycerides (Triacylglycerol)
3. Transcription Factors (Transcription Factor)
4. Polyphenols
5. Peroxisome Proliferator-Activated Receptors (PPAR)
6. Cytokines
7. Messenger RNA (mRNA)
8. Phosphotransferases (Kinase)
9. Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
10. I-kappa B Kinase

Related Therapies and Procedures

1. Therapeutics